{"id":91963,"date":"2016-12-13T12:22:34","date_gmt":"2016-12-13T12:22:34","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=91963"},"modified":"2016-12-13T12:22:34","modified_gmt":"2016-12-13T12:22:34","slug":"global-spine-biologics-market-will-be-worth-usd-27-billion-by-2022-new-market-report-by-data-bridge-market-research","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-spine-biologics-market-will-be-worth-usd-27-billion-by-2022-new-market-report-by-data-bridge-market-research_91963.html","title":{"rendered":"Global Spine Biologics Market will be worth USD 2.7 billion by 2022 – New market report by Data Bridge Market Research"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“”Global Spine Biologics Market is expected to grow at 4.4% in the forecast period 2016 to 2022″”<\/div>\n<\/div>\n<\/div>\n
Global Spine Biologics Market By Product (Bone Allografts, Bone Graft Substitute, Platelet Rich Plasma, Bone Marrow Aspirate Therapy), By End-User (Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Others), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) \u2013 Trends and Forecast to 2022 <\/div>\n

Global Spine Biologics Market is expected to reach USD 2.7 billion by 2022, growing at a CAGR of 4.4% during the forecast period of 2016 to 2022.<\/p>\n

Global Spine Biologics Market are segmented based on product type, end-user and geography.<\/p>\n

On the basis of product type the spine biologics market is segmented into bone grafts; bone graft substitutes; platelet-rich plasma (PRP) and bone marrow aspirate therapy among others.<\/p>\n

For Sample Report: <\/strong>Global Spine Biologics Market – Trends and Forecast to 2022<\/a><\/p>\n

Based on surgery type, the market is segmented into Anterior Cervical Discectomy and Fusion (ACDF); Transforamenal Lumbar Interbody Fusion (TLIF); Anterior Lumbar Interbody Fusion (ALIF); Lateral Lumbar Interbody Fusion (LLIF) among others.<\/p>\n

Based on end-users the market is segmented into Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Others.<\/p>\n

\"\"<\/p>\n

Based on geography the market is segmented into geographical regions such as North America, Europe, South America, Asia-Pacific, and Rest of the World (RoW). The report includes company share analysis for the major companies operating in this market by major regions North America, Europe and Asia Pacific.<\/p>\n

To read more about the scope and findings of this report visit:<\/strong> Global Spine Biologics Market is poised to grow at 4.3% from 2016 to 2022<\/a><\/p>\n

On the basis of application the market is segmented into orthopedic, ENT, neurosurgery dental and others.<\/p>\n

Based on end-users the Surgical Navigation Systems and Software market is segmented into hospitals and ambulatory surgical centers.<\/p>\n

Based on geography the Surgical Navigation Systems and Software market is segmented into North & South America, Europe, Asia-Pacific and, Middle East & Africa. The report of this market shares countries such as U.S., Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among other companies.<\/p>\n

\"\"<\/p>\n

KEY PLAYERS OPERATING IN GLOBAL SPINE BIOLOGICS MARKET:<\/strong><\/p>\n